Literature DB >> 10837836

A model of the Parkinsonian visual system: support for the dark adaptation hypothesis.

B Wink1, J Harris.   

Abstract

Considerable evidence suggests that some visual abnormalities in Parkinson's disease are mediated by disruption of dopaminergic processes in the retina. Since dopamine is thought to be involved in the process of dark adaptation, and some of these abnormalities are similar to the changes which accompany dark adaptation in normal subjects, it has been proposed that the parkinsonian retina behaves as though inappropriately dark-adapted. In Parkinson's disease, the apparent contrast of peripherally viewed medium and high spatial frequency gratings is reduced. In our first experiment, normal subjects were dark-adapted, and were required to match the apparent contrast of a peripherally viewed grating to that of a foveally viewed grating. The results showed an interaction between spatial frequency and dark adaptation, reflecting a greater reduction in the apparent contrast of peripheral high spatial frequency gratings. In a second experiment, no effect of dark adaptation was found on the apparent spatial frequency of a peripherally viewed grating required to match that of a foveally viewed grating. The first experiment supports the dark adaptation hypothesis of parkinsonian vision, and the second suggests that the changes in apparent contrast are mediated by different amounts of change in contrast gain in central and peripheral vision, rather than by differential changes in receptive field size.

Entities:  

Mesh:

Year:  2000        PMID: 10837836     DOI: 10.1016/s0042-6989(00)00036-5

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  9 in total

1.  Light- and dopamine-regulated receptive field plasticity in primate horizontal cells.

Authors:  Ai-Jun Zhang; Roy Jacoby; Samuel M Wu
Journal:  J Comp Neurol       Date:  2011-08-01       Impact factor: 3.215

2.  D1 and D2 receptor-mediated dopaminergic modulation of visual responses in cat dorsal lateral geniculate nucleus.

Authors:  Yongqiang Zhao; Nicolas Kerscher; Ulf Eysel; Klaus Funke
Journal:  J Physiol       Date:  2002-02-15       Impact factor: 5.182

Review 3.  Hallucinations in Parkinson disease.

Authors:  Nico J Diederich; Gilles Fénelon; Glenn Stebbins; Christopher G Goetz
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

4.  Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder.

Authors:  Garrett E Alexander
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

5.  Abnormal susceptibility to distracters hinders perception in early stage Parkinson's disease: a controlled study.

Authors:  Jan Berend Deijen; Diederick Stoffers; Henk W Berendse; Erik Ch Wolters; Jan Theeuwes
Journal:  BMC Neurol       Date:  2006-12-11       Impact factor: 2.474

6.  Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson's disease (PD).

Authors:  Barbara Nowacka; Wojciech Lubiński; Krystyna Honczarenko; Andrzej Potemkowski; Krzysztof Safranow
Journal:  Doc Ophthalmol       Date:  2015-05-14       Impact factor: 2.379

7.  Ophthalmological features of Parkinson disease.

Authors:  Barbara Nowacka; Wojciech Lubinski; Krystyna Honczarenko; Andrzej Potemkowski; Krzysztof Safranow
Journal:  Med Sci Monit       Date:  2014-11-11

Review 8.  Visual dysfunction in Parkinson's disease.

Authors:  Rimona S Weil; Anette E Schrag; Jason D Warren; Sebastian J Crutch; Andrew J Lees; Huw R Morris
Journal:  Brain       Date:  2016-11-01       Impact factor: 15.255

9.  Parkinson's disease, lights and melanocytes: looking beyond the retina.

Authors:  Gregory L Willis; Cleo Moore; Stuart Maxwell Armstrong
Journal:  Sci Rep       Date:  2014-01-29       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.